高透性遗传变异对乳腺外科手术的影响
Matthew G Davey1, Shona Tormey2
1Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Breast Surgery, University Hospital Limerick, Limerick, Ireland.
Clinical breast cancer
|January 13, 2024
概括
遗传遗传变异影响5-10%的乳腺癌病例. 了解这些致病变体对于早期诊断,降低风险的手术和在现代手术实践中管理男性乳腺癌至关重要.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 在外科手术实践中.
背景情况:
- 遗传基因变异占乳腺癌诊断的5-10%.
- 这些变异对临床管理和患者的治疗结果有重大影响.
研究的目的:
- 讨论高度透的遗传变异对乳腺癌的影响.
- 为了突出对当代乳腺外科实践的影响.
主要方法:
- 关于遗传性乳腺癌遗传学的当前文献的综述.
- 对手术管理的临床影响的分析.
主要成果:
- 早期识别遗传变异使积极的风险减轻策略成为可能.
- 致病变体影响管理决策,包括降低风险的手术.
- 对于具有遗传变异的男性乳腺癌患者,需要特别考虑.
结论:
- 将遗传变异知识整合到乳腺外科手术中,对于个性化患者护理至关重要.
- 遗传性癌症遗传学正在改变乳腺癌诊断和治疗模式.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
12.3K
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13.1K
相关概念视频
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...